
GRTSQ
Healthcare · Biotechnology
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 14, 2024 | Time not confirmed | — | -0.16 | — |
| May 10, 2024 | Time not confirmed | — | -0.34 | — |
| Mar 6, 2024 | Time not confirmed | — | -0.32 | — |
| Nov 9, 2023 | Time not confirmed | — | -0.33 | — |
| Aug 10, 2023 | Time not confirmed | — | -0.31 | — |
| May 12, 2023 | Time not confirmed | — | -0.30 | — |
| Mar 10, 2023 | Time not confirmed | — | -0.36 | — |
| Nov 4, 2022 | Time not confirmed | — | -0.35 | — |
| Aug 5, 2022 | Time not confirmed | — | -0.34 | — |
| May 6, 2022 | Time not confirmed | — | -0.34 | — |
| Mar 11, 2022 | Time not confirmed | — | -0.43 | — |
| Nov 4, 2021 | Time not confirmed | — | -0.36 | — |
| Aug 6, 2021 | Time not confirmed | — | -0.33 | — |
| May 6, 2021 |
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing vaccine-based immunotherapy candidates against cancer and infectious diseases. Its primary product candidate is GRANITE, an individualized immunotherapy candidate, which is in Phase 2/3 clinical trials for the treatment of microsatellite stable colorectal cancers; and has completed Phase 1/2 clinical trials for treating solid tumors.…
| Time not confirmed |
| — |
| 0.10 |
| — |
| Mar 11, 2021 | Time not confirmed | — | -0.69 | — |
| Nov 5, 2020 | Time not confirmed | — | -0.69 | — |
| Aug 5, 2020 | Time not confirmed | — | -0.69 | — |
| May 7, 2020 | Time not confirmed | — | -0.71 | — |
| Mar 11, 2020 | Time not confirmed | — | -0.77 | — |
| Nov 12, 2019 | Time not confirmed | — | -0.77 | — |
| Aug 12, 2019 | Time not confirmed | — | -0.63 | — |
| May 13, 2019 | Time not confirmed | — | -0.62 | — |
| Mar 29, 2019 | Time not confirmed | — | -0.61 | — |
| Nov 14, 2018 | Time not confirmed | — | -7.60 | — |